The global ophthalmic lasers market size is expected to reach USD 3.41 billion in 2028 at a CAGR of 5.3%. Ophthalmic lasers are the medical devices used to treat various ophthalmic disorders by targeting ophthalmic cells with the help of laser beam. These are used for various therapeutic and diagnostic procedures such as cataract, glaucoma, diabetic retinopathy, retinal tears, and macular edema among others. The selection of ophthalmic laser is depends on disease condition. For instance, green laser is used in diabetic retinopathy for photocoagulation. Increase in the prevalence of various ophthalmic disorders such as diabetic retinopathy and glaucoma is anticipated to propel the ophthalmic lasers market. Moreover, technological advancements in laser technology, grow in geriatric population, high accuracy with laser treatment, rise in awareness among the people about the ophthalmic lasers treatment, and increase in healthcare expenditure are propel the ophthalmic lasers market over the forecast timeframe. However, stringent regulatory guidelines, high cost of lasers, lack of skilled practitioners, and complications with the ophthalmic lasers are hinder the growth of the market.
In June 2016, Ellex Medical Lasers Limited received China Food and Drug Administration approval for YAG laser portfolio